Feedback / Questions
PB016 (vedolizumab biosimilar) - Genefar
https://www.businesswire.com/news/home/20250805925297/en/Polpharma-Biologics-and-Fresenius-Kabi-Sign-Licensing-Agreement-for-Proposed-Vedolizumab-Biosimilar-PB016
Aug 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next